eCite Digital Repository

The atypical chemokine receptor CCX-CKR scavenges homeostatic chemokines in circulation and tissues and suppresses Th17 responses

Citation

Comerford, I and Nibbs, RJB and Litchfield, W and Bunting, M and Harata-Lee, Y and Haylock-Jacobs, S and Forrow, S and Korner, H and McColl, SR, The atypical chemokine receptor CCX-CKR scavenges homeostatic chemokines in circulation and tissues and suppresses Th17 responses, Blood, 116, (20) pp. 4130-4140. ISSN 0006-4971 (2010) [Refereed Article]


Preview
PDF
Restricted - Request a copy
635Kb
  

Copyright Statement

Copyright ©2010 American Society of Hematology

Official URL: http://bloodjournal.hematologylibrary.org/content/...

DOI: doi:10.1182/blood-2010-01-264390

Abstract

Our previous in vitro studies led to proposals that the atypical chemokine receptor CCX-CKR is a scavenger of CCR7 ligand homeostatic chemokines. In the present study, we generated CCX-CKR/ mice and confirm this scavenger function in vivo. Compared with wild-type mice, CCX-CKR/ have a 5-fold increase in the level of CCL21 protein in blood, and 2- to 3-fold increases in CCL19 and CCL21 in peripheral lymph nodes. The effect of these protein increases on immunity was investigated after immunization with MOG35-55 peptide emulsified in complete Freund adjuvant (CFA). The subsequent characteristic paralysis develops with enhanced kinetics and severity in CCXCKR / versus wild-type mice. Despite this effect, antigen-specific immune responses in the draining lymph nodes are diminished in CCX-CKR/ mice. Instead, the earlier onset of disease is associated with enhanced T-cell priming in the CCXCKR / spleen and a skewing of CD4 T-cell responses toward Th17 rather than Th1. This observation correlates with increased expression of IL-23 in the CCXCKR / spleen and increased CCL21 levels in the central nervous system postimmunization. The early onset of disease in CCX-CKR/ mice is reversed by systemic administration of neutralizing anti-CCL21 antibodies. Thus, by regulating homeostatic chemokine bioavailability, CCX-CKR influences the localization, kinetics, and nature of adaptive immune responses in vivo.

Item Details

Item Type:Refereed Article
Research Division:Medical and Health Sciences
Research Group:Immunology
Research Field:Immunology not elsewhere classified
Objective Division:Health
Objective Group:Clinical Health (Organs, Diseases and Abnormal Conditions)
Objective Field:Immune System and Allergy
Author:Korner, H (Professor Heinrich Korner)
ID Code:67862
Year Published:2010
Web of Science® Times Cited:33
Deposited By:Menzies Institute for Medical Research
Deposited On:2011-03-08
Last Modified:2011-05-09
Downloads:0

Repository Staff Only: item control page